We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current LVCLF market cap is 11.29M. The company's latest EPS is AUD -0.0013 and P/E is -7.69.
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Revenue | 647k | 450k | 244k | 0 | 0 |
| Operating Income | -3.47M | -1.55M | -1.91M | -2.38M | -2.13M |
| Net Income | -3.18M | -968k | -1.46M | -1.96M | -2.11M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Total Assets | 5.76M | 3.39M | 1.64M | 4.27M | 4.21M |
| Total Liabilities | 1.62M | 513k | 265k | 239k | 450k |
| Total Equity | 4.14M | 2.88M | 1.38M | 4.04M | 3.76M |
| Year End 30 June 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | AUD (AUD) | |
| Operating | -1.99M | -3.11M | -1.46M | -2.04M | -1.99M |
| Investing | -53k | 1.24M | 106k | 39k | N/A |
| Financing | N/A | -50k | -45k | 4.69M | 1.85M |
| Market Cap | 11.29M |
| Price to Earnings Ratio | -7.69 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 4 |
| Price to Book Ratio | 4.35 |
| Dividend Yield | - |
| Shares Outstanding | 1.64B |
| Average Volume (1 week) | 47.83k |
| Average Volume (1 Month) | 47.83k |
| 52 Week Change | 13.11% |
| 52 Week High | 0.0127 |
| 52 Week Low | 0.0037 |
| Spread (Intraday) | 0.01 (78.72%) |
| Company Name | Algorae Pharmaceuticals Ltd (PK) |
| Address |
level 7 melbourne, victoria 3000 |
| Website | https://www.lctglobal.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
